Halozyme Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $54.9M | $65.8M | $52.4M |
| FY2012 | $85.9M | $134.7M | $99.5M |
| FY2013 | $121.8M | $101.8M | $27.4M |
| FY2014 | $124.6M | $166.0M | $61.4M |
| FY2015 | $138.8M | $181.8M | $43.3M |
| FY2016 | $294.0M | $261.5M | $66.8M |
| FY2017 | $311.6M | $519.9M | $168.7M |
| FY2018 | $191.4M | $440.2M | $57.9M |
| FY2019 | $474.1M | $565.9M | $120.2M |
| FY2020 | $428.9M | $579.9M | $147.7M |